NDC properties for "Pradaxa 30 MG Oral Pellet" (RxCUI 2590629)
About this data
The tables show NDC propoerties for Pradaxa 30 MG Oral Pellet with the RxCUI 2590629
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product
Details for Pradaxa 30 MG Oral Pellet (RxCUI 2590629)
| MMSL_CODE | BD39052 |
|---|---|
| NDA | NDA214358 |
| RxCUI | 2590629 |
| SPL_SET_ID | 9ac0a64a-8666-45f7-9d4f-40fd894f7e6d |
| Prescribable Synonym | Pradaxa 30 MG Oral Pellet |
| RXNAV_STR | Pradaxa 30 MG Oral Pellet |
| RxNorm Name | dabigatran etexilate 30 MG Oral Pellet [Pradaxa] |
| RxNorm Synonym | Pradaxa 30 MG Oral Pellet |
| Related queries | Interactions (for RxCUI 2590629) |
NDC Properties
NDC Item 00597043018
| NDC 9 | 0597-0430 |
|---|---|
| NDC 10 | 0597-0430-18 |
| NDC Item | 00597043018 |
| Packaging | 1 BAG in 1 CARTON (0597-0430-18) / 60 PELLET in 1 BAG |
| COLORTEXT | YELLOW(yellow-white) |
| Color | C48330 __ |
| FDA SPL set id | 749356 |
| Labeler | Boehringer Ingelheim Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2022-03-16 |
| Marketing status | ACTIVE |
| NDA | NDA214358 |
| Related queries | Properties for NDC 9 0597-0430 |